Investigating how certain proteins affect insulin signaling and cognitive decline in aging and Alzheimer's disease

WNK1/OSR1 axis in Hippocampal Insulin Signaling, Glucose Metabolism and Age-related Cognitive Dysfunction

NIH-funded research Ut Southwestern Medical Center · NIH-10746867

This study is looking at how certain proteins in the brain affect how our bodies use insulin and manage sugar, which could help us understand why some older adults experience memory problems or Alzheimer's disease, with hopes of finding new ways to support brain health as we age.

Quick facts

Grant typeCareer grant
Study typeNIH-funded research
Funding institutionUt Southwestern Medical Center NIH-funded
Lab location1 site (Dallas, United States)
Project IDNIH-10746867 on NIH RePORTER

What this research studies

This research focuses on understanding the role of specific proteins, WNK1 and OSR1, in the insulin signaling pathways that influence glucose metabolism in the brain, particularly in the hippocampus. The study aims to uncover how disruptions in these pathways may contribute to cognitive decline associated with aging and Alzheimer's disease. By using animal models, the research will explore the mechanisms behind insulin resistance in neurons and its impact on cognitive functions. The findings could lead to new insights into potential therapeutic targets for improving cognitive health in older adults.

Who could benefit from this research

Good fit: Ideal candidates for this research are older adults experiencing cognitive decline or those diagnosed with Alzheimer's disease.

Not a fit: Patients with cognitive impairments not related to aging or Alzheimer's disease may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to new treatments that improve cognitive function and slow the progression of Alzheimer's disease in aging patients.

How similar studies have performed: Previous research has shown promising results in understanding insulin signaling in relation to cognitive decline, suggesting that this approach could yield valuable insights.

Where this research is happening

Dallas, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Alzheimer disease dementiaAlzheimer syndromeAlzheimer's Disease
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.